February 27, 2025 How the House’s Budget Plan Sets the Stage for a Fiscal Showdown
Tesla's Energy Unit Emerges as a Growth Catalyst
March 12, 2025 Features of exchanging USDC ERC20 to Bank Transfer
February 19, 2025 Why Stock Caps Matter When Building a Diversified Portfolio
February 5, 2025 Top 5 Coins for the Maximum Passive Income from Staking by 2024
January 21, 2025 Trading Stocks With AI: A Modern Approach
January 21, 2025 Bitcoin Is Great, but Here Are 3 Altcoins Worth Considering in 2025
Turning Point Therapeutics (TPTX) Stock Forecast for 2025, 2026, 2027. Sell or Buy?
Updated: March 17, 2025 (18:35)
Sector: HealthcareThe share price of Turning Point Therapeutics, Inc. (TPTX) now
Are you interested in Turning Point Therapeutics, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Turning Point Therapeutics stock price in 2025, 2026, 2027. How much will one Turning Point Therapeutics share be worth in 2025 - 2027?
When should I take profit in Turning Point Therapeutics stock? When should I record a loss on Turning Point Therapeutics stock? What are analysts' forecasts for Turning Point Therapeutics stock? What is the future of Turning Point Therapeutics stock? We forecast Turning Point Therapeutics stock performance using neural networks based on historical data on Turning Point Therapeutics stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Turning Point Therapeutics stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2025, 2026, 2027, and ) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Turning Point Therapeutics shares. This happens once a day.
Historical and forecast chart of Turning Point Therapeutics stock
The chart below shows the historical price of Turning Point Therapeutics stock and a prediction chart for the next month.
For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast,
and Weighted Average Best Forecast. Detailed values for the Turning Point Therapeutics stock price can be found in the table below.
Long-term forecasts by years.
Turning Point Therapeutics, Inc., a clinical stage biopharmaceutical company, designs and develops new small molecule targeted cancer therapies. He is developing a suite of tyrosine kinase inhibitors (TKIs) that targets cancer genetic factors in previously TKI-naive and TKI-treated patients.
Turning Point Therapeutics daily forecast for a month
| Date | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Mar 19 | 78.48 | 75.27 | 80.78 | 7.32 |
| Mar 20 | 80.17 | 77.57 | 82.48 | 6.33 |
| Mar 21 | 75.60 | 72.56 | 77.42 | 6.69 |
| Mar 22 | 71.61 | 69.29 | 73.33 | 5.83 |
| Mar 23 | 74.75 | 73.00 | 77.62 | 6.33 |
| Mar 24 | 74.25 | 72.74 | 77.68 | 6.80 |
| Mar 25 | 75.23 | 71.94 | 77.53 | 7.78 |
| Mar 26 | 74.87 | 72.22 | 77.52 | 7.34 |
| Mar 27 | 77.84 | 76.16 | 80.26 | 5.40 |
| Mar 28 | 75.97 | 73.83 | 77.11 | 4.45 |
| Mar 29 | 73.19 | 72.09 | 74.72 | 3.65 |
| Mar 30 | 74.86 | 73.60 | 76.65 | 4.15 |
| Mar 31 | 77.28 | 75.61 | 79.97 | 5.76 |
| Apr 01 | 75.47 | 74.07 | 78.69 | 6.24 |
| Apr 02 | 76.15 | 74.14 | 79.63 | 7.40 |
| Apr 03 | 77.48 | 73.94 | 78.73 | 6.48 |
| Apr 04 | 78.18 | 76.96 | 79.11 | 2.80 |
| Apr 05 | 76.91 | 73.96 | 78.02 | 5.49 |
| Apr 06 | 78.99 | 75.43 | 81.78 | 8.42 |
| Apr 07 | 77.71 | 74.86 | 80.60 | 7.66 |
| Apr 08 | 76.87 | 74.24 | 78.20 | 5.34 |
| Apr 09 | 78.67 | 77.06 | 80.32 | 4.23 |
| Apr 10 | 78.67 | 75.83 | 79.66 | 5.04 |
| Apr 11 | 80.32 | 78.05 | 82.82 | 6.11 |
| Apr 12 | 78.39 | 74.77 | 81.87 | 9.50 |
| Apr 13 | 76.65 | 73.80 | 79.36 | 7.54 |
| Apr 14 | 77.57 | 74.26 | 80.04 | 7.77 |
| Apr 15 | 79.34 | 76.15 | 81.05 | 6.44 |
| Apr 16 | 77.53 | 74.09 | 79.20 | 6.91 |
| Apr 17 | 73.30 | 70.31 | 76.07 | 8.19 |
Turning Point Therapeutics Daily Price Targets
Turning Point Therapeutics Stock Forecast 03-19-2025.
Forecast target price for 03-19-2025: $78.48.
Positive dynamics for Turning Point Therapeutics shares will prevail with possible volatility of 6.820%.
Pessimistic target level: 75.27
Optimistic target level: 80.78
Turning Point Therapeutics Stock Forecast 03-20-2025.
Forecast target price for 03-20-2025: $80.17.
Positive dynamics for Turning Point Therapeutics shares will prevail with possible volatility of 5.949%.
Pessimistic target level: 77.57
Optimistic target level: 82.48
Turning Point Therapeutics Stock Forecast 03-21-2025.
Forecast target price for 03-21-2025: $75.60.
Negative dynamics for Turning Point Therapeutics shares will prevail with possible volatility of 6.269%.
Pessimistic target level: 72.56
Optimistic target level: 77.42
Turning Point Therapeutics Stock Forecast 03-22-2025.
Forecast target price for 03-22-2025: $71.61.
Negative dynamics for Turning Point Therapeutics shares will prevail with possible volatility of 5.508%.
Pessimistic target level: 69.29
Optimistic target level: 73.33
Turning Point Therapeutics Stock Forecast 03-23-2025.
Forecast target price for 03-23-2025: $74.75.
Positive dynamics for Turning Point Therapeutics shares will prevail with possible volatility of 5.951%.
Pessimistic target level: 73.00
Optimistic target level: 77.62
Turning Point Therapeutics Stock Forecast 03-24-2025.
Forecast target price for 03-24-2025: $74.25.
Negative dynamics for Turning Point Therapeutics shares will prevail with possible volatility of 6.366%.
Pessimistic target level: 72.74
Optimistic target level: 77.68
TPTX (TPTX) Monthly Stock Prediction for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Apr. | 82.03 | 73.55 | 88.71 | 17.09 |
| May. | 84.02 | 76.62 | 97.14 | 21.12 |
| Jun. | 92.33 | 84.61 | 108.58 | 22.07 |
| Jul. | 86.64 | 72.73 | 98.65 | 26.28 |
| Aug. | 70.82 | 65.21 | 75.03 | 13.08 |
| Sep. | 69.11 | 60.90 | 73.98 | 17.68 |
| Oct. | 61.96 | 56.92 | 72.32 | 21.30 |
| Nov. | 67.14 | 61.09 | 73.05 | 16.38 |
| Dec. | 73.50 | 66.70 | 84.65 | 21.20 |
Turning Point Therapeutics forecast for this year
Turning Point Therapeutics Stock Prediction for Apr 2025
An uptrend is forecast for this month with an optimal target price of $82.03. Pessimistic: $73.55. Optimistic: $88.71
Turning Point Therapeutics Stock Prediction for May 2025
An uptrend is forecast for this month with an optimal target price of $84.0151. Pessimistic: $76.62. Optimistic: $97.14
Turning Point Therapeutics Stock Prediction for Jun 2025
An uptrend is forecast for this month with an optimal target price of $92.3326. Pessimistic: $84.61. Optimistic: $108.58
Turning Point Therapeutics Stock Prediction for Jul 2025
An downtrend is forecast for this month with an optimal target price of $86.6449. Pessimistic: $72.73. Optimistic: $98.65
Turning Point Therapeutics Stock Prediction for Aug 2025
An downtrend is forecast for this month with an optimal target price of $70.8236. Pessimistic: $65.21. Optimistic: $75.03
Turning Point Therapeutics Stock Prediction for Sep 2025
An downtrend is forecast for this month with an optimal target price of $69.1096. Pessimistic: $60.90. Optimistic: $73.98
Turning Point Therapeutics Stock Prediction for Oct 2025
An downtrend is forecast for this month with an optimal target price of $61.9637. Pessimistic: $56.92. Optimistic: $72.32
Turning Point Therapeutics Stock Prediction for Nov 2025
An uptrend is forecast for this month with an optimal target price of $67.1439. Pessimistic: $61.09. Optimistic: $73.05
Turning Point Therapeutics Stock Prediction for Dec 2025
An uptrend is forecast for this month with an optimal target price of $73.4957. Pessimistic: $66.70. Optimistic: $84.65
Turning Point Therapeutics (TPTX) Monthly Stock Prediction for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 57.81 | 49.42 | 66.59 | 25.79 |
| Feb | 47.38 | 40.82 | 51.24 | 20.34 |
| Mar | 37.90 | 31.23 | 43.82 | 28.73 |
| Apr | 35.23 | 31.74 | 40.89 | 22.37 |
| May | 32.83 | 27.05 | 34.56 | 21.73 |
| Jun | 31.74 | 30.14 | 33.84 | 10.94 |
| Jul | 38.03 | 31.67 | 42.55 | 25.56 |
| Aug | 44.80 | 40.57 | 51.41 | 21.09 |
| Sep | 50.13 | 42.19 | 57.52 | 26.65 |
| Oct | 58.51 | 50.14 | 65.07 | 22.95 |
| Nov | 57.35 | 50.79 | 63.66 | 20.22 |
| Dec | 47.63 | 42.40 | 53.50 | 20.76 |
Turning Point Therapeutics (TPTX) Monthly Stock Prediction for 2027
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 43.65 | 37.89 | 46.73 | 18.91 |
| Feb | 41.16 | 35.45 | 43.24 | 18.01 |
| Mar | 44.05 | 37.37 | 48.41 | 22.82 |
| Apr | 49.00 | 44.36 | 53.63 | 17.28 |
| May | 51.47 | 45.81 | 60.42 | 24.18 |
| Jun | 47.51 | 43.75 | 50.44 | 13.26 |
| Jul | 45.94 | 41.80 | 48.67 | 14.12 |
| Aug | 44.63 | 40.11 | 51.80 | 22.56 |
| Sep | 34.81 | 30.06 | 38.26 | 21.42 |
| Oct | 27.31 | 25.20 | 31.93 | 21.07 |
| Nov | 25.44 | 21.53 | 28.13 | 23.48 |
| Dec | 23.04 | 20.76 | 24.86 | 16.51 |
Turning Point Therapeutics information and performance
N/A
Market capitalization of the Turning Point Therapeutics, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of TPTX shares in the company outstanding by the market price of one share.
EBITDA of Turning Point Therapeutics is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
FAQ (Frequently Asked Questions about Turning Point Therapeutics Stock)
Should I Buy Turning Point Therapeutics Shares in 2025 year?
Does Turning Point Therapeutics pay dividends?
Which economic sector do Turning Point Therapeutics's shares belong to?
Which other securities belong to the same sector as Turning Point Therapeutics's shares?
Related stocks from Healthcare sector
